Monitor for additional selling in next 30 days — isolated sales post-grant are common, but continued outflows could signal concern. The stock awards suggest confidence in long-term equity value.
Price Chart
Executive Summary
Tectonic Therapeutic insiders executed a mix of open-market sales and non-cash derivative/award transactions over the past week. The Chief Medical Officer and Chief Scientific Officer sold a combined $481,410 worth of shares, while all executives received substantial stock awards totaling hundreds of thousands in non-cash compensation. The open-market selling represents a modest 0.07% of market cap and is likely routine post-vesting disposition.
Key Financial Metrics
Key Facts
- Chief Medical Officer Marcella Ruddy sold $300,000 in shares on March 6 at $30/share.
- Chief Scientific Officer Peter McNamara sold $217,786 in shares across two dates (March 3 and March 6) at prices between $22.06 and $30.
- All C-suite executives received stock grants on March 4 totaling over $400,000 in non-cash value based on current share price.
- McNamara also exercised options for 5,000 shares, one tranche at $0 and another at $2.38 strike price.
- Total open-market sales in cluster: $481,410 (~0.07% of $674M market cap).
Financial Impact
$481,410 in open-market insider selling over 7 days, offset by $0-cost stock awards totaling ~$427,500 (based on 143,000 shares at $30).
Risk Factors
- Perception of insider selling may weigh on sentiment despite routine nature.
- Concentration of transactions around stock award vesting/exercise dates could indicate tax-planning activity rather than conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-TECX-1773094548558 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 9w ago | 144 | $36.47 | awaiting T+60 | — | $19.95 (−45.30%) |
Jun 11, 2026 19w ago | Institutional Cluster | $29.34 $30.75 | ▲ +4.81% | ▲ +0.41% | $19.95 (−32.00%) |
May 7, 2026 24w ago | 8-K | $29.00 $29.17 | ▼ −0.59% | ▲ +4.25% | $19.95 (+31.21%) |
May 7, 2026 24w ago | Press Release | $29.00 $29.17 | ▲ +0.59% | ▼ −4.25% | $19.95 (−31.21%) |
Apr 24, 2026 26w ago | DEFA14A | $28.75 $31.59 | ▲ +9.88% | ▲ +5.10% | $19.95 (−30.61%) |
Apr 3, 2026 29w ago | 3 | $29.98 $32.74 | ▲ +9.21% | ▼ −4.26% | $19.95 (−33.46%) |
Mar 6, 2026 33w ago | Insider Cluster | $35.87 $28.89 | ▼ −19.46% | ▼ −32.24% | $19.95 (−44.38%) |
Feb 24, 2026 35w ago | 8-K | $23.11 $28.84 | ▲ +24.79% | ▲ +17.84% | $19.95 (−13.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers